2003
DOI: 10.1038/sj.eye.6700333
|View full text |Cite
|
Sign up to set email alerts
|

Corneal replacement using a synthetic hydrogel cornea, AlphaCor™: device, preliminary outcomes and complications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
72
0
3

Year Published

2004
2004
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 128 publications
(76 citation statements)
references
References 5 publications
1
72
0
3
Order By: Relevance
“…Over time, the polymer is hydrolyzed resulting in erosion of the matrix. [8] These PHEMA hydrogels have been shown to be useful for cell immobilization, [9][10][11] coating drug delivery devices for neural micro-electrode arrays, [12] artificial skin, [13] corneal replacements and repairs, [6,14] controlled drug release, [15] and as synthetic articular cartilage. [16,17] Understanding the degradation of PHEMA films is important because both porosity and hydrogel formation depend on how the film degrades over time.…”
Section: Introductionmentioning
confidence: 99%
“…Over time, the polymer is hydrolyzed resulting in erosion of the matrix. [8] These PHEMA hydrogels have been shown to be useful for cell immobilization, [9][10][11] coating drug delivery devices for neural micro-electrode arrays, [12] artificial skin, [13] corneal replacements and repairs, [6,14] controlled drug release, [15] and as synthetic articular cartilage. [16,17] Understanding the degradation of PHEMA films is important because both porosity and hydrogel formation depend on how the film degrades over time.…”
Section: Introductionmentioning
confidence: 99%
“…1 In such circumstances, the use of an artificial cornea, or keratoprosthesis (Kpro), plays a significant role in providing visual rehabilitation. Many Kpro devices have been developed over the past decades, including AlphaCor, 2,3 Boston Keratoprosthesis (Boston Kpro), 4 osteo-odonto keratoprosthesis (OOKP), 5 and the Moscow Eye Microsurgery Complex in Russia (MICOF) keratoprosthesis. 6,7 The Boston Kpro and OOKP, the most commonly used Kpros, have been used to treat patients with multiple graft failures, aniridia, chemical injuries, Stevens-Johnson syndrome, ocular cicatricial pemphigoid, and thermal burns as well as other conditions with high risk of corneal graft rejection and failure.…”
mentioning
confidence: 99%
“…Although several models of KPros have been designed for clinical use, few models have received FDA approval and are currently on the market. 15,28 The most critical problem of clinically approved KPros is bioincompatibility, followed by extrusion, glucoma, and endophthalmitis. Improvements in the design and materials of KPros are therefore necessary to increase tissue biointegration and biocompatibility and to prevent extrusion.…”
Section: Discussionmentioning
confidence: 99%